Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,545,798
+$2,161,048 QoQ
Shares Held
57,804
+1.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#754
of 4,153 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Siemens Fonds Invest GmbH holds $98,160,775 across 10 Drug Manufacturers - General names. ABBV ranks #3 (14.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,769 | $24,910,963 | |
| 2 | JNJ |
Johnson & Johnson
|
81,643 | $20,734,872 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
57,804 | $14,545,798 | |
| 4 | AMGN |
Amgen Inc
|
28,142 | $10,190,781 | |
| 5 | MRK |
Merck & Co., Inc.
|
75,099 | $9,650,221 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
59,147 | $7,472,631 | |
| 7 | PFE |
Pfizer Inc
|
226,573 | $5,455,877 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
76,062 | $4,382,692 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,545,798 | 57,804 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,384,750 | 56,944 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,208,092 | 57,806 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $14,859,311 | 64,176 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,611,644 | 62,556 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,359,794 | 58,991 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,557,963 | 65,042 | Shares | Sole | 2025-03-04 | |
| 2024-09-30 | $11,907,846 | 60,299 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,421,898 | 60,762 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,986,457 | 60,332 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $9,575,441 | 61,789 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,748,822 | 65,402 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,593,314 | 71,204 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $11,475,277 | 72,004 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $12,006,491 | 74,293 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,134,599 | 75,513 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,581,806 | 75,619 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $12,325,709 | 76,033 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $10,246,936 | 75,679 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,630,139 | 80,005 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,640,276 | 76,707 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $8,178,510 | 75,573 | Shares | Sole | 2021-07-14 | |
| 2020-12-31 | $8,169,437 | 76,243 | Shares | Sole | 2021-07-14 | |
| No filing history on record for this holder in this stock. | ||||||